230 related articles for article (PubMed ID: 1330049)
1. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
[TBL] [Abstract][Full Text] [Related]
2. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
Browning J; Ribolini A
J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
[TBL] [Abstract][Full Text] [Related]
3. Biological activity of mutants of human tumour necrosis factor-alpha.
Kircheis R; Milleck J; Korobko VG; Shingarova LN; Behnke D; Schmidt HE
Immunology; 1992 Jul; 76(3):433-8. PubMed ID: 1526652
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
5. Human TNF mutants with selective activity on the p55 receptor.
Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W
Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906
[TBL] [Abstract][Full Text] [Related]
6. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
Biochem Mol Biol Int; 1996 Apr; 38(4):855-62. PubMed ID: 8728116
[TBL] [Abstract][Full Text] [Related]
7. The relationship of receptor occupancy to the kinetics of cell death mediated by tumor necrosis factor.
Coffman FD; Green LM; Ware CF
Lymphokine Res; 1988; 7(4):371-83. PubMed ID: 2850412
[TBL] [Abstract][Full Text] [Related]
8. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
[TBL] [Abstract][Full Text] [Related]
9. Lymphotoxin and TNF differ greatly in capacity to induce differentiation of human myeloblastic leukemia ML-1 cells.
Takeda K; Iwamoto S; Takeda M
Biochem Mol Biol Int; 1994 Apr; 32(6):1109-19. PubMed ID: 8061628
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells.
Dunne SL; Bajzer Z; Vuk-Pavlović S
Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
Andrews JS; Berger AE; Ware CF
J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
[TBL] [Abstract][Full Text] [Related]
12. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
Biochem Mol Biol Int; 1996 May; 38(6):1183-9. PubMed ID: 8739040
[TBL] [Abstract][Full Text] [Related]
13. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-alpha.
Kramer SM; Aggarwal BB; Eessalu TE; McCabe SM; Ferraiolo BL; Figari IS; Palladino MA
Cancer Res; 1988 Feb; 48(4):920-5. PubMed ID: 2827889
[TBL] [Abstract][Full Text] [Related]
15. Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor.
Shieh JH; Peterson RH; Warren DJ; Moore MA
J Immunol; 1989 Oct; 143(8):2534-9. PubMed ID: 2551961
[TBL] [Abstract][Full Text] [Related]
16. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
Kamijo R; Takeda K; Nagumo M; Konno K
J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines.
Totpal K; Aggarwal BB
Cancer Res; 1991 Aug; 51(16):4266-70. PubMed ID: 1651157
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
19. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines.
Tsujimoto M; Feinman R; Vilcek J
J Immunol; 1986 Oct; 137(7):2272-6. PubMed ID: 3020123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
